Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

United Health Throws It's Backing Behind Gilead's Harvoni

|Includes: ABBV, GILD, UnitedHealth Group Inc. (UNH)

UnitedHealth (NYSE:UNH) on Wednesday backed Gilead's (NASDAQ:GILD) hepatitis C treatment Harvoni on its 2015 commercial drug coverage list over AbbVie's (NYSE:ABBV) Viekira Pak.

The coverage list which is effective February 1st, applies to all of UNH's commercial fully insured customers who use its Optum Rx PBM and self-insured customers such as employers who follow the list.

UNH Vice President Tyler Mason states "We are constantly working to deliver value and manage costs for customers and consumers throughout our business.".

Disclosure: The author is long GILD.